Trinity Biotech revenue comes in light

|About: Trinity Biotech PLC (TRIB)|By:, SA News Editor

Trinity Biotech (TRIB -3.1%) Q2: Diluted EPS (ex-Medical Devise Excise Tax) of $0.176.

Revenue of $21.3M (+2.4% Y/Y) misses by $0.7M.

The company also says it is acquiring Immco Diagnostics for $32.75M, a deal TRIB says will be "immediately earnings accretive." (PR)